Thierry Chignon has more than 25 years of experience in Quality Assurance, Regulatory Affairs, Clinical Trials with particular focus on the medical device sector, including a first experience as Head Pharmacist with Institut Mérieux (10 years). As Director with Quintiles Consulting, between 1997 and 2006, he defined and participated in the implementation of business development strategies for innovative products in Europe. Thierry also worked for 5 years as an expert of the Commission of the European Union drafting Guidelines and Regulations for medical devices.
In 2006, Thierry joined Matignon Investissement to raise and deploy the first French fund dedicated to European medical technologies (Matignon Technologies II, 80M€), including oversight of 8 investments (50% Growth Capital, 50% Venture Capital). Thierry joined Mérieux Développement in 2014, as Senior Partner, to support the launch and management of Mérieux Participations 2. Thierry holds a Degree in Pharmacy, a Master Degree from IEP Paris (Sciences Politiques) and an executive MBA from HEC Paris.
CURRENT RESPONSIBILITIES & BOARD POSITION
- Board Member of Novacap, Ineldea and Biobest (Growth Capital)
- Board Member of Supersonic Imagine (Venture Capital)